Raquelle I Mesholam-Gately

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi Verbal learning and memory in older adults with minor and major depression
    Raquelle I Mesholam-Gately
    Harvard Medical School, Department of Psychiatry, Massachusetts Mental Health Center, Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
    Arch Clin Neuropsychol 27:196-207. 2012
  2. ncbi Neurocognition in first-episode schizophrenia: a meta-analytic review
    Raquelle I Mesholam-Gately
    Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Department of Psychiatry, Harvard Medical School, MA, USA
    Neuropsychology 23:315-36. 2009
  3. ncbi A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia
    Robert W Buchanan
    Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Maple and Locust Streets, Baltimore, MD 21228, USA
    Biol Psychiatry 69:442-9. 2011
  4. ncbi Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review
    Anthony J Giuliano
    Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Harvard Medical School Department of Psychiatry, Boston, Massachusetts 02115, USA
    Curr Pharm Des 18:399-415. 2012

Detail Information

Publications4

  1. ncbi Verbal learning and memory in older adults with minor and major depression
    Raquelle I Mesholam-Gately
    Harvard Medical School, Department of Psychiatry, Massachusetts Mental Health Center, Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Boston, MA 02115, USA
    Arch Clin Neuropsychol 27:196-207. 2012
    ..The findings suggest that depression in the elderly is a heterogeneous entity and that the CVLT may be a useful tool for characterizing learning and memory in late-onset depressive disorders...
  2. ncbi Neurocognition in first-episode schizophrenia: a meta-analytic review
    Raquelle I Mesholam-Gately
    Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Department of Psychiatry, Harvard Medical School, MA, USA
    Neuropsychology 23:315-36. 2009
    ..Considerable heterogeneity of effect sizes across studies, however, underscores variability in manifestations of the illness and a need for improved reporting of sample characteristics to support moderator variable analyses...
  3. ncbi A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia
    Robert W Buchanan
    Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Maple and Locust Streets, Baltimore, MD 21228, USA
    Biol Psychiatry 69:442-9. 2011
    ..The current study was designed to further examine the efficacy and safety of MK-0777 for the treatment of cognitive impairments in schizophrenia...
  4. ncbi Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review
    Anthony J Giuliano
    Massachusetts Mental Health Center Public Psychiatry Division of the Beth Israel Deaconess Medical Center, Harvard Medical School Department of Psychiatry, Boston, Massachusetts 02115, USA
    Curr Pharm Des 18:399-415. 2012
    ....